NEW YORK (Reuters Health) – In patients with moderate-to-severe chronic obstructive pulmonary disease, twice daily inhalation of either 200 or 400 mcg aclidinium bromide significantly improves FEV1, and…
NEW YORK (Reuters Health) – In looking back at more than 30,000 patients who had major open abdominal surgery over a five-year period, researchers found that those who…
NEW YORK (Reuters Health) – It’s safe and beneficial to start small volumes of milk feeds early, between 24 and 48 hours after birth, in babies who are…
NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results…
NEW YORK (Reuters Health) – Patients with rheumatoid arthritis (RA) who are prescribed statin therapy for hypercholesterolemia or ischemic heart disease are at increased risk of death from…
NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of…
NEW YORK (Reuters Health) – Cigarette smoking enhanced the effects of clopidogrel in a study of diabetics with coronary artery disease. Accordingly, smokers were less likely to experience…
NEW YORK (Reuters Health) – An investigational phosphodiesterase type 5 (PDE5) inhibitor, avanafil, is an effective and well tolerated treatment for erectile dysfunction (ED), according to the results…
NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in first-time users of oral bisphosphonates. “Patients taking bisphosphonates must be familiar…
NEW YORK (Reuters Health) – An investigational formulation of azelastine and fluticasone (MP29-02) is more effective than either agent alone as intranasal therapy for moderate-to-severe seasonal allergic rhinitis…